Previous Article | Next Article 
Infection and Immunity, November 1999, p. 6048-6055, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
De Novo Induction of Atherosclerosis by
Chlamydia pneumoniae in a Rabbit Model
Ignatius W.
Fong,1,*
Brian
Chiu,2
Esther
Viira,2
Dan
Jang,3 and
James B.
Mahony3
Departments of
Medicine1 and Laboratory Medicine and
Pathobiology,2 St. Michael's Hospital,
University of Toronto, Toronto, and McMaster University,
Hamilton,3 Ontario, Canada
Received 3 March 1999/Returned for modification 26 April
1999/Accepted 4 August 1999
Chlamydia pneumoniae, a bacterial respiratory tract
pathogen, has been associated with atherosclerosis in humans. C. pneumoniae infection of the respiratory tracts of rabbits fed a
noncholesterol diet induced changes of atherosclerosis of the aorta in
6 (26.1%) of 23 animals after a single inoculum at 3 months. Multiple
inocula given three times within 6 weeks resulted in grade III
atherosclerosis in 8 (34.8%) of 23 rabbits, with an additional 5 (21.7%) showing increased myxoid changes in the intima-media junction
and exhibiting 8 (34.8%) focal periaortitis. Control animals
inoculated with carrier broth (n = 24), HEp-2 cells
(n = 12), or another respiratory pathogen,
Mycoplasma pneumoniae (n = 32), produced
no changes of atherosclerosis after 3 months. The histological changes
were dissimilar (fewer foam cells) from those of rabbits fed a 0.5% cholesterol diet but were highly similar to or indistinguishable from
changes in rabbits fed a 0.15% cholesterol diet (similar to that of
humans). Proinflammatory cytokines and tissue growth factors were more
consistently detected in cholesterol-induced aortic lesions than those
induced by C. pneumoniae. These data are compatible with de
novo induction of atherogenesis by C. pneumoniae in rabbits
and suggest that C. pneumoniae may be important in the
pathogenesis of atherosclerosis in humans.
*
Corresponding author. Mailing address: Division of
Infectious Diseases, St. Michael's Hospital, 30 Bond St., Room 4179V,
Toronto, Ontario M5B 1W8, Canada. Phone: (416) 864-5746. Fax: (416)
864-5310. E-mail: fongi{at}smh.toronto.on.ca.
Infection and Immunity, November 1999, p. 6048-6055, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Schmeck, B., Beermann, W., N'Guessan, P. D., Hocke, A. C., Opitz, B., Eitel, J., Dinh, Q. T., Witzenrath, M., Krull, M., Suttorp, N., Hippenstiel, S.
(2008). Simvastatin Reduces Chlamydophila pneumoniae-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells. Circ. Res.
102: 888-895
[Abstract]
[Full Text]
-
Tormakangas, L., Erkkila, L., Korhonen, T., Tiirola, T., Bloigu, A., Saikku, P., Leinonen, M.
(2005). Effects of Repeated Chlamydia pneumoniae Inoculations on Aortic Lipid Accumulation and Inflammatory Response in C57BL/6J Mice. Infect. Immun.
73: 6458-6466
[Abstract]
[Full Text]
-
Cochrane, M., Walker, P., Gibbs, H., Timms, P.
(2005). Multiple genotypes of Chlamydia pneumoniae identified in human carotid plaque. Microbiology
151: 2285-2290
[Abstract]
[Full Text]
-
Opitz, B., Forster, S., Hocke, A. C., Maass, M., Schmeck, B., Hippenstiel, S., Suttorp, N., Krull, M.
(2005). Nod1-Mediated Endothelial Cell Activation by Chlamydophila pneumoniae. Circ. Res.
96: 319-326
[Abstract]
[Full Text]
-
de Kruif, M. D., van Gorp, E. C.M., Keller, T. T., Ossewaarde, J. M., ten Cate, H.
(2005). Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research. Cardiovasc Res
65: 317-327
[Abstract]
[Full Text]
-
Tormakangas, L., Alakarppa, H., David, D. B., Leinonen, M., Saikku, P.
(2004). Telithromycin Treatment of Chronic Chlamydia pneumoniae Infection in C57BL/6J mice. Antimicrob. Agents Chemother.
48: 3655-3661
[Abstract]
[Full Text]
-
Hirono, S., Dibrov, E., Hurtado, C., Kostenuk, A., Ducas, R., Pierce, G. N.
(2003). Chlamydia pneumoniae Stimulates Proliferation of Vascular Smooth Muscle Cells Through Induction of Endogenous Heat Shock Protein 60. Circ. Res.
93: 710-716
[Abstract]
[Full Text]
-
Higgins, J. P.
(2003). Chlamydia pneumoniae and Coronary Artery Disease: The Antibiotic Trials. Mayo Clin Proc.
78: 321-332
[Abstract]
-
Pislaru, S. V, Van Ranst, M., Pislaru, C., Szelid, Z., Theilmeier, G., Ossewaarde, J.M, Holvoet, P., Janssens, S., Verbeken, E., Van de Werf, F. J
(2003). Chlamydia pneumoniae induces neointima formation in coronary arteries of normal pigs. Cardiovasc Res
57: 834-842
[Abstract]
[Full Text]
-
Wang, G., Burczynski, F., Hasinoff, B., Zhong, G.
(2002). Infection of myocytes with chlamydiae. Microbiology
148: 3955-3959
[Abstract]
[Full Text]
-
Karunakaran, K. P., Blanchard, J. F., Raudonikiene, A., Shen, C., Murdin, A. D., Brunham, R. C.
(2002). Molecular Detection and Seroepidemiology of the Chlamydia pneumoniae Bacteriophage ({Phi}Cpn1). J. Clin. Microbiol.
40: 4010-4014
[Abstract]
[Full Text]
-
Ezzahiri, R, Nelissen-Vrancken, H.J.M.G, Kurvers, H.A.J.M, Stassen, F.R.M, Vliegen, I, Grauls, G.E.L.M, van Pul, M.M.L, Kitslaar, P.J.E.H.M, Bruggeman, C.A
(2002). Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice. Cardiovasc Res
56: 269-276
[Abstract]
[Full Text]
-
Fong, I. W., Chiu, B., Viira, E., Jang, D., Mahony, J. B.
(2002). Influence of Clarithromycin on Early Atherosclerotic Lesions after Chlamydia pneumoniae Infection in a Rabbit Model. Antimicrob. Agents Chemother.
46: 2321-2326
[Abstract]
[Full Text]
-
FONG, I. W.
(2002). Infections and their role in atherosclerotic vascular disease. Journal of the American Dental Association
133: 7S-13S
[Abstract]
[Full Text]
-
Burian, K., Berencsi, K., Endresz, V., Gyulai, Z., Valyi-Nagy, T., Valyi-Nagy, I., Bakay, M., Geng, Y., Virok, D., Kari, L., Hajnal-Papp, R., Trinchieri, G., Gonczol, E.
(2001). Chlamydia pneumoniae Exacerbates Aortic Inflammatory Foci Caused by Murine Cytomegalovirus Infection in Normocholesterolemic Mice. CVI
8: 1263-1266
[Abstract]
[Full Text]
-
Streblow, D. N., Orloff, S. L., Nelson, J. A.
(2001). Do Pathogens Accelerate Atherosclerosis?. J. Nutr.
131: 2798S-2804
[Abstract]
[Full Text]
-
Aalto-Setala, K., Laitinen, K., Erkkila, L., Leinonen, M., Jauhiainen, M., Ehnholm, C., Tamminen, M., Puolakkainen, M., Penttila, I., Saikku, P.
(2001). Chlamydia pneumoniae Does Not Increase Atherosclerosis in the Aortic Root of Apolipoprotein E-Deficient Mice. Arterioscler. Thromb. Vasc. Bio.
21: 578-584
[Abstract]
[Full Text]
-
Grayston, J. T.
(2000). Secondary Prevention Antibiotic Treatment Trials for Coronary Artery Disease. Circulation
102: 1742-1743
[Full Text]
-
Blessing, E., Lin, T.-M., Campbell, L. A., Rosenfeld, M. E., Lloyd, D., Kuo, C.-c.
(2000). Chlamydia pneumoniae Induces Inflammatory Changes in the Heart and Aorta of Normocholesterolemic C57BL/6J Mice. Infect. Immun.
68: 4765-4768
[Abstract]
[Full Text]
-
Fong, I. W.
(2000). Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ
163: 49-56
[Abstract]
[Full Text]
-
Mahony, J. B., Chong, S., Coombes, B. K., Smieja, M., Petrich, A.
(2000). Analytical Sensitivity, Reproducibility of Results, and Clinical Performance of Five PCR Assays for Detecting Chlamydia pneumoniae DNA in Peripheral Blood Mononuclear Cells. J. Clin. Microbiol.
38: 2622-2627
[Abstract]
[Full Text]